- Country: Poland
- Summary: Successive Delivery of Drugs for the Treatment of Hepatitis C in 2024 as Part of the Drug Program Financed by the National Health Fund for the Needs of the Wrocław Health Center Spzoz
- PLT Ref No: 93420069
- Deadline: 10 Jan 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 747196-2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the order is the successive delivery of drugs for the treatment of hepatitis C as part of the drug program financed by the National Health Fund for the needs of the Wrocław Health Center SPZOZ.
The order was divided into three separate Parts:
Part No. 1 - Delivery of the preparation includesGlecaprevir pibrentasvir
Part No. 1 of the order includes the supply of 220 packages (84 tablets/pack) of a preparation containing 100 mg of glecaprevir and 40 mg of pibrentasvir (Glecaprevirum Pibrentasvirum 100 mg 40 mg) in one tablet, indicated for the treatment of chronic inflammation virus infectionhepatitis C (HCV) in adults and adolescents aged 12 to Part No. 2 - Delivery of a preparation containing Sofosbuvir velpatasvir
Part No. 2 of the order includes the delivery of 75 packages (28 tablets/pack) of a preparation containing 400 mg of sofosbuvir and 100 mg of velpatasvir in one tablet, indicated in treatmentprevention of chronic hepatitis C virus (HCV) infection in adults and adolescents aged 12 to Part No. 3 - Delivery of a preparation containing Sofosbuvir velpatasvir and voxilaprevir
Part No. 3 of the order includes the delivery of 9 packages (28 tablets/pack) of the preparation containing 400mg sofosbuvir, 100 mg of velpatasvir and 100 mg of voxilaprevir in one tablet, indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults, used under the National Health Fund B.71 drug program - TREATMENT OF CHRONIC HEPATITIS C WITH INTERFERON-FREE THERAPY
... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSuccessive Delivery of Drugs for the Treatment of Hepatitis C in 2024 as Part of the Drug Program Financed by the National Health Fund for the Needs of the Wrocław Health Center Spzoz - Poland Tender
The WROCŁAW HEALTH CENTER INDEPENDENT PUBLIC HEALTH CARE FACILITY, a Government sector organization in Poland, has announced a new tender for Successive Delivery of Drugs for the Treatment of Hepatitis C in 2024 as Part of the Drug Program Financed by the National Health Fund for the Needs of the Wrocław Health Center Spzoz. This tender is published on PolandTenders under PLT Ref No: 93420069 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-01-10.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
